Relation between development of cardiovascular disease and the C242T CYBA polymorphism of the NADPH oxidase in ESRD patients

Disease Markers

Volumn 29, Issue 2, 2010, Pages 89-93

  Tang, Feng Ying ^a   Zhu, Ying ^a   Wang, Gui Hua ^a   Xie, Xiong Wei ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

cardiovascular disease; gene polymorphism; NAD(P)H Oxidase

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TRIACYLGLYCEROL;

ADULT; ARTICLE; C242T GENE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE; GENOTYPE; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 78649497805     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2010/143907     Document Type: Article

References (24)

1. Z.D. Vaziri, Z. Ni, F. Oveisi, K. Liang and R. Pandian, Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency, Hypertension 39 (2002), 135-141.
2. M. Annuk, M. Zilmer and B. Fellstrom, Endotheliumdependent vasodilation and oxidative stress in chronic renal failure: impact on cardiovascular disease, Kidney Int Suppl 84 (2003), S50-S53.
3. P.S. Modlinger, C.S. Wilcox and S. Aslam, Nitric oxide, oxidative stress, and progression of chronic renal failure, Semin Nephrol 24(4) (2004), 354-365.
4. M. UshioFukai, A.M. Zafari, T. Fukui, N. Ishizaka and K.K. Griendling, P22phox is a critical component of the superoxidegenerating NADH/NADPH oxidase system and regulates angiotensin IIinduced hypertrophy in vascular smooth muscle cells, J Biol Chem 271 (1996), 23317-23321.
5. D. Sorescu, D. Weiss, B. Lassegue et al., Superoxide production and expression of nox family proteins in human atherosclerosis, Circulation 105 (2002), 1429-1435.
6. K.M. Mohazzab, P.M. Kaminski and M.S. Wolin, NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium, Am J Physiol 266 (1994), H2568-H2572.
7. K.K. Griendling, C.A. Minieri, J.D. Ollerenshaw and R.W. Alexander, Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells, Circ Res 74 (1994), 1141-1148.
8. S. Rajagopalan, S. Kurz, T. Munzel et al., Angiotensin IImediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone, J Clin Invest 97 (1996), 1916-1923.
9. N. Inoue, S. Kawashima, K. Kanazawa et al., Polymorphism of the NADH/NADPH oxidase p22phox gene in patients with coronary artery disease, Circulation 97 (1998), 135-137.
10. H. Kimura, F. Gejyo, T. Yamaguchi et al., A cholesteryl ester transfer protein gene mutation and vascular disease in dialysis patients, J Am Soc Nephrol 10 (1999), 294-299. (Pubitemid 29068068)
11. Y. Allanore, D. Borderie, H. Lemarechal et al., Lack of association of eNOS (G894T) and p22phox NAPDH oxidase subunit (C242T) polymorphisms with systemic sclerosis in a cohort of French Caucasian patients, Clinica Chimica Acta (2004), 51-55.
12. M.C. Dinauer, E.A. Pierce, G.A. Bruns, J.T. Curnutte and S.H. Orkin, Human neutrophil cytochrome b light chain(p22phox): gene structure, chromosomal location, and mutations in cytochromenegative autosomal recessive chronic granulomatous disease, J Clin Invest 86 (1990), 1729-1737.
13. M.S.Wolin, How could a genetic variant of the p22phox component of NADPH oxidases contribute to the progression of coronary atherosclerosis? Circ Res 86 (2000), 365-366.
14. T.J. Guzik, N.E. West, E. Black et al., Functional effect of the C242T polymorphism in the NADPH oxidase p22phox gene on vascular superoxide production in atherosclerosis, Circulation 102 (2000), 1744-1747.
15. A. Gardemann, P. Mages, N. Katz, Tillmanns and W. Haberbosh, The p22phox A640G gene polymorphism but not the C242T gene variation is associated with coronary heart disease in younger individuals, Atherosclerosis 145 (1999), 315-323.
16. C. Cahilly, C.M. Ballantyne, D.S. Lim, A. Gotto and A.J. Marian, A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis, Circ Res 86 (2000), 391-395.
17. D. Ito, M. Murata, K. Watanabe et al., C242T polymorphism of NADPH oxidase p22PHOX gene and ischemic cerebrovascular disease in the Japanese population, Stroke 31 (2000), 936-939.
18. O. Stanger, W. Renner, G. Khoschsorur, B. Riglar and T.C. Wascher, NADH/NADPH oxidase p22phox C242T polymorphism and lipid peroxidation in coronary artery disease, Clin Physiol 21 (2001), 718-722. (Pubitemid 33114710)
19. H. Cai, N. Duarte, D.E. Wilcken and X.L. Wang, NADH/NADPH oxidase p22phox C242T polymorphism and coronary artery disease in the Australian population, Eur J Clin Invest 29 (1999), 744-748.
20. R. HayaishiOkano, Y. Yamasaki, Y. Kajimoto et al., Association of NADPH oxidase p22phox gene variation with advanced cartoid atherosclerosis in Japanese type 2 diabetes, Diabetes Care 26 (2003), 458-463.
21. S.MatsunagaIrie, T.Maruyama, Y. Yamamoto et al., Relation between development of nephropathy and the p22phox C242T and receptor for advanced glycation end product G1704T gene polymorphisms in type 2 diabetic patients, Diabetes Care 27 (2004), 303-307.
22. A.D. Hodgkinson, B.A. Millward and A.G. Demaine, Association of the p22phox component of NAD(P)H oxidase with susceptibility to diabetic nephropathy in patients with type 1 diabetes, Diabetes Care 26 (2003), 3111-3115.
23. G.Wolf,U. Panzer, S.Harendza, U.Wenzel andR.A. Stahl, No association between a genetic variant of the p22(phox) component of NAD(P)H oxidase and the incidence and progression of IgA nephropathy, Nephrol Dial Transplant 17 (2002), 1509-1512.
24. K. Doi, E. Noiri, A. Nakao et al., Haplotype analysis of NAD(P)H oxidase p22 phox polymorphisms in endstage renal disease, J Hum Genet 50 (2005), 641-647.